1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Relapsing Remitting Multiple Sclerosis: new trials by email Literature Review of Relapsing Remitting Multiple Sclerosis trials Research Report on Relapsing Remitting Multiple Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2 Study of Orelabrutinib in Patients With Relapsing-Remitting Multiple Sclerosis placebo, orelabrutinib - Relapsing Remitting Multiple Sclerosis | Phase 2 | Unknown | Beijing InnoCare Pharma Tech Co., Ltd. | 160 | 2021-03-01 | 2023-04-21 |
Multiple Sclerosis, Relapsing-Remitting (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Immune System Diseases (1) · Multiple Sclerosis (1) · Nervous System Diseases (1)
orelabrutinib (1)
Beijing InnoCare Pharma Tech Co., Ltd. (1)
China (1) · Poland (1) · Ukraine (1) · United States (1)